[go: up one dir, main page]

AU7370594A - Methods of treating apoptosis and associated conditions - Google Patents

Methods of treating apoptosis and associated conditions

Info

Publication number
AU7370594A
AU7370594A AU73705/94A AU7370594A AU7370594A AU 7370594 A AU7370594 A AU 7370594A AU 73705/94 A AU73705/94 A AU 73705/94A AU 7370594 A AU7370594 A AU 7370594A AU 7370594 A AU7370594 A AU 7370594A
Authority
AU
Australia
Prior art keywords
methods
associated conditions
treating apoptosis
apoptosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73705/94A
Inventor
L. David Tomei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LXR Biotechnology Inc
Original Assignee
LXR Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LXR Biotechnology Inc filed Critical LXR Biotechnology Inc
Publication of AU7370594A publication Critical patent/AU7370594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU73705/94A 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions Abandoned AU7370594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9678893A 1993-07-23 1993-07-23
US096788 1993-07-23
PCT/US1994/008268 WO1995003054A1 (en) 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions

Publications (1)

Publication Number Publication Date
AU7370594A true AU7370594A (en) 1995-02-20

Family

ID=22259083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73705/94A Abandoned AU7370594A (en) 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions

Country Status (7)

Country Link
EP (1) EP0711168A4 (en)
JP (1) JPH09503749A (en)
KR (1) KR960703597A (en)
AU (1) AU7370594A (en)
BR (1) BR9407145A (en)
CA (1) CA2167805A1 (en)
WO (1) WO1995003054A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3866800B2 (en) 1996-08-29 2007-01-10 東菱薬品工業株式会社 Prophylactic and / or therapeutic agent for apoptosis-related diseases
US6693100B1 (en) 1999-09-10 2004-02-17 Iervant Zarmanian Pharmaceutical compositions for treating psoriasis
SK2802002A3 (en) * 1999-09-10 2003-02-04 Cyathus Exquirere Pharmaforsch The use of dexrazoxane, an article comprising dexrazoxane, method for treating psoriasis and method for producing a drug
US6552025B1 (en) 1999-11-24 2003-04-22 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
WO2001037836A1 (en) * 1999-11-24 2001-05-31 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
CA2417960C (en) 2000-08-04 2012-07-10 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
CN103191409A (en) 2003-05-15 2013-07-10 Dmi生物科学公司 Treatment of T-cell mediated diseases
MXPA05014216A (en) * 2003-06-24 2006-03-13 Univ Connecticut Methods of inhibiting vascular permeability and apoptosis.
GB0314733D0 (en) * 2003-06-24 2003-07-30 Glaxo Group Ltd Medicaments
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
JP2013537195A (en) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション Disease treatment
PL2766029T3 (en) 2011-10-10 2020-08-24 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
PH12014500686A1 (en) 2011-10-10 2020-12-18 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
US10881710B2 (en) 2011-10-28 2021-01-05 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20170045274A (en) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 Treatment of joint conditions
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916072D0 (en) * 1989-07-13 1989-08-31 Creighton Andrew M Pharmaceutical compositions
GB9024861D0 (en) * 1990-11-15 1991-01-02 Hellmann Kurt Bis-dioxopiperazines for treating liver tumors

Also Published As

Publication number Publication date
WO1995003054A1 (en) 1995-02-02
CA2167805A1 (en) 1995-02-02
EP0711168A4 (en) 1998-04-01
JPH09503749A (en) 1997-04-15
KR960703597A (en) 1996-08-31
BR9407145A (en) 1996-09-17
EP0711168A1 (en) 1996-05-15

Similar Documents

Publication Publication Date Title
ZA965088B (en) Methods of preventing or treating allergles
AU7419096A (en) Treatment of vegetables
AU6797094A (en) Cosmetic treatment of substrates
AU3519893A (en) Antitumor compositions and methods of treatment
AU7370594A (en) Methods of treating apoptosis and associated conditions
AU2103295A (en) Methods for the treatment of thrombosis
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3937593A (en) Trans-sialidase and methods of use and making thereof
AU1115095A (en) Treatment of cellulose
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU5644494A (en) Surface treated applicators and related methods
AU2207897A (en) Methods of treating or preventing interstitial cystitis
AU1394795A (en) Method and device for the continuous cooking of pulp
AU7065694A (en) Catheter and method of use thereof
AU6821994A (en) Electrode-carrying catheter and method of making same
AU3730093A (en) Methods of treating diabetes
AU6369094A (en) Ige isoforms and methods of use
AU675283B2 (en) Method of treating night soil and apparatus therefor
AU5528996A (en) Methods of treating or preventing pain or nociception
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU3973793A (en) Method of treating cancer
AU1429792A (en) Method for the treatment of the sewages and respective plant
EP0583687A3 (en) Method for the preparation of substituted methoxyphenols and microorganisms therefore
AU7113996A (en) Methods of treating beta-amyloid-associated conditions